CA$
15. 00
0
0%
CA$
127.34M Market Cap
- P/E Ratio
0.13% Div Yield
29,109 Volume
- Eps
CA$ 15
Previous Close Want to track RX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.15 | 0.14 |
| | | 0.14 | 0.2 |
| | | 0.1 | 0.13 |
| | | - | - |
| | | 0.1 | 0.12 |
| | | 0.1 | - |
| | | 0.08 | 0.08 |
| | | - | 0.07 |
| | | - | 0.07 |
| | | 0.05 | 0.07 |
| | | 0.08 | 0.08 |
| | | 0.07 | 0.06 |
| | | 0.05 | 0.07 |
| | | 0.04 | 0.05 |
| | | - | 0.07 |
| | | - | 0.06 |
RX Earnings Reports FAQ
What is the earnings per share (EPS) for RX?
EPS data for RX is currently not available, as Biosyent Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 8.59%, reflecting the RX's performance and TSX-V market conditions.
When is the next earnings release date?
Biosyent Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Biosyent Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RX at this time, as Biosyent Inc has no recent EPS data to calculate it.
